| Ms Luciana C Berceanu, MD | |
|
4131 W. Loomis Rd, Ste 300, Greenfield, WI 53221-2059 | |
| (414) 325-7246 | |
| (414) 325-3770 |
| Full Name | Ms Luciana C Berceanu |
|---|---|
| Gender | Female |
| Speciality | Interventional Pain Management |
| Experience | 40 Years |
| Location | 4131 W. Loomis Rd, Greenfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629033055 | NPI | - | NPPES |
| 34076700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 42886 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Marys Hospital | Rhinelander, WI | Hospital |
| Ascension Eagle River Hospital | Eagle river, WI | Hospital |
| Howard Young Medical Center | Woodruff, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
News Archive
A new report from an American Cancer Society (ACS) scientific advisory subcommittee on cancer and the environment says exposure to carcinogens should be minimized or eliminated whenever feasible, and calls for new strategies to more effectively and efficiently screen the large number of chemicals to which the public is exposed.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 9 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
A new report from an American Cancer Society (ACS) scientific advisory subcommittee on cancer and the environment says exposure to carcinogens should be minimized or eliminated whenever feasible, and calls for new strategies to more effectively and efficiently screen the large number of chemicals to which the public is exposed.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 9 days ago
| Entity Name | Advanced Pain Management Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770506669 PECOS PAC ID: 1456257633 Enrollment ID: O20031209000560 |
News Archive
A new report from an American Cancer Society (ACS) scientific advisory subcommittee on cancer and the environment says exposure to carcinogens should be minimized or eliminated whenever feasible, and calls for new strategies to more effectively and efficiently screen the large number of chemicals to which the public is exposed.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 9 days ago
| Entity Name | Howard Young Medical Center Inc Of Woodruff Wisconsin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184673352 PECOS PAC ID: 4183519606 Enrollment ID: O20040419000970 |
News Archive
A new report from an American Cancer Society (ACS) scientific advisory subcommittee on cancer and the environment says exposure to carcinogens should be minimized or eliminated whenever feasible, and calls for new strategies to more effectively and efficiently screen the large number of chemicals to which the public is exposed.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Luciana C Berceanu, MD 4131 W. Loomis Rd, Ste 300, Greenfield, WI 53221-2059 Ph: (414) 325-7246 | Ms Luciana C Berceanu, MD 4131 W. Loomis Rd, Ste 300, Greenfield, WI 53221-2059 Ph: (414) 325-7246 |
News Archive
A new report from an American Cancer Society (ACS) scientific advisory subcommittee on cancer and the environment says exposure to carcinogens should be minimized or eliminated whenever feasible, and calls for new strategies to more effectively and efficiently screen the large number of chemicals to which the public is exposed.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 9 days ago
Dr. Bhupinder S Saini, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 4131 W. Loomis Rd, Ste 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 | |
Hany Radwan Nosir, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 4131 W Loomis Rd, Ste 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 | |
Dr. Scott Aschenbrener, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 4131 W Loomis Rd, Ste 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 | |
Dr. Mark K Aasen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4131 W. Loomis Rd, Ste 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 | |
Dr. Dermot J. More O'ferrall, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 4131 W. Loomis Rd., Ste 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 | |
Kris Ferguson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4131 W Loomis Rd, Suite 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 | |
Dr. Harry A Tagalakis, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4131 W. Loomis Rd., Ste 300, Greenfield, WI 53221 Phone: 414-325-7246 Fax: 414-325-3770 |